loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Ketamine Hydrochloride

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Ketamine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 330Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NRX-100 (Ketamine) Reaches Stability Milestone
    NRX-100 (Ketamine) Reaches Stability Milestone

    30 Sep 2024

    // CONTRACT PHARMA

    https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-announces-completion-of-twelve-months-of-stability-on-the-first-manufactured-commercial-scale-lot-of-nrx-100-ketamine-302262032.html

    CONTRACT PHARMA
    30 Sep 2024
    Share Share
    Ketabon To Present At-Home Ketamine Therapy At ECNP 2024
    Ketabon To Present At-Home Ketamine Therapy At ECNP 2024

    18 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/18/2948187/0/en/Ketabon-To-Present-Advancements-In-At-Home-Ketamine-Therapy-For-Treatment-Resistant-Depression-At-ECNP-Congress-2024.html

    GLOBENEWSWIRE
    18 Sep 2024
    Share Share
    PharmaTher Announces Update on FDA NDA for Ketamine
    PharmaTher Announces Update on FDA NDA for Ketamine

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940433/0/en/PharmaTher-Announces-Update-on-FDA-New-Drug-Application-for-Ketamine.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    SciSparc-Clearmind Ketamine-Based Combination Patent Application Published
    SciSparc-Clearmind Ketamine-Based Combination Patent Application Published

    29 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/29/2938125/0/en/SciSparc-Clearmind-Medicine-Collaboration-Leads-to-Publication-of-Application-for-Innovative-Ketamine-Based-Combination.html

    GLOBENEWSWIRE
    29 Aug 2024
    Share Share
    Psychemedics Corporation Launches New Ketamine Hair Testing Service
    Psychemedics Corporation Launches New Ketamine Hair Testing Service

    29 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/29/2937825/0/en/Psychemedics-Corporation-Launches-New-Ketamine-Hair-Testing-Service.html

    GLOBENEWSWIRE
    29 Aug 2024
    Share Share
    MIRA Pharmaceuticals Announces Ketamir-2 Shows Promising Safety Profile
    MIRA Pharmaceuticals Announces Ketamir-2 Shows Promising Safety Profile

    24 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mira-pharmaceuticals-announces-ketamir-2-shows-promising-safety-profile-in-comparison-to-traditional-ketamine-in-preclinical-testing-302179730.html

    PR NEWSWIRE
    24 Jun 2024
    Share Share